Pharma 310505 SRL
Pharma 310505 reported total assets of €1.08m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of Pharma 310505 shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1025 % Total assets +196 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma 310505's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 28,950 € | ||||
| Equity | 413,071 € | ||||
| Cash | 409,138 € | ||||
| EBITDA | 108,632 € | ||||
| Total assets | €1.08m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 22 May 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
- Year ended 31 Dec 2021filed on 01 Jun 2022
Pharma 310505's financial analysis
- Solvency38.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma 310505
Pharma 310505's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0643.802.856
- VAT number
- BE0643802856
- Peppol
- Registered · 0208:0643802856 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Dec 2015
- Registered office
- 8000 Bruges
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma 310505 (SRL) has been based in Bruges since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 28,950 € and equity of 413,071 €; its revenue is not published. Its solvency stands at 38.3%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma 310505
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Discry Retail sale of pharmaceutical products Grâce-Hollogne · balance sheet €1.20m
- Apotheek Loksbergen Retail sale of pharmaceutical products Halen · balance sheet €1.15m
- Vandaele Pharma Retail sale of pharmaceutical products Aalter · balance sheet €1.36m
- W.A. Farma Retail sale of pharmaceutical products Kontich · balance sheet €1.09m
- Farmacie Céline Desmet Retail sale of pharmaceutical products Heuvelland · balance sheet €1.06m
- Piers Retail sale of pharmaceutical products Ostend · balance sheet €1.05m
- Approver Retail sale of pharmaceutical products Lier · balance sheet 704,844 €
- Ma Ressource Santé Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet €1.17m
Frequently asked questions about Pharma 310505
What is the revenue of Pharma 310505?
Pharma 310505 files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma 310505?
In Belgium, the VAT number is the company number prefixed with BE: BE0643802856 for Pharma 310505, if the company is VAT-registered. Its company number (CBE) is 0643.802.856.
Where is the registered office of Pharma 310505?
According to the CBE register, the registered office of Pharma 310505 is in 8000 Bruges.
What is the equity of Pharma 310505?
At the close of the 2025 financial year, the equity of Pharma 310505 amounts to 413,071 €, a solvency of 38.3% of total assets.
Who manages Pharma 310505?
The register lists 7 active mandates at Pharma 310505. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma 310505
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →